← Nano X Imaging overview

Nano X Imaging vs US Dollar/Korean Won FX Spot Rate: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Nano X Imaging Ltd (NNOX)

Q3 2026
▼3

Nano-X: Q2 revenue up 37% but going-concern doubt and lawsuits weigh

  • Securities class action lawsuits pile up Multiple law firms filed class actions alleging Nano-X overstated efficiency and demand, hid rising costs and cash burn, and misled investors. Legal costs, potential damages, and reputational damage weigh on the stock, though the suits are still pending.

    This is a major new legal overhang that directly pressures NNOX shares.

  • Going-concern doubt after Q2 report Nano-X ended Q2 with $31.4 million cash, down from $60 million, and management warned of substantial doubt about continuing as a going concern. A $40.7 million impairment and $55.5 million net loss deepen fears of a cash crunch, pushing the stock down.

    Going-concern doubt is a severe new risk that directly threatens the company's survival and stock price.

  • Revenue growth but slow commercialization Q2 revenue rose 37% to $4.2 million, with teleradiology up 14% and AI/software adding $1 million. The first Nanox Imaging Network site began collecting insurance payments, but management admitted commercialization is slower than expected, tempering the positive growth.

    This shows the underlying business is growing but not fast enough to offset cash burn, a key tension for the stock.

  • Restructuring and manufacturing shift Nano-X is idling its South Korean chip fabrication, cutting that workforce by 67% and Israeli headcount by 15%, and shifting to third-party manufacturing. The plan saves only $2 million a year from 2027, raising doubts about its impact.

    The restructuring is a direct response to the cash crisis and signals deeper operational problems.

August 2026
▼3

Nano-X: Q2 revenue up 37% but going-concern doubt and lawsuits weigh

  • Securities class action lawsuits pile up Multiple law firms filed class actions alleging Nano-X overstated efficiency and demand, hid rising costs and cash burn, and misled investors. Legal costs, potential damages, and reputational damage weigh on the stock, though the suits are still pending.

    This is a major new legal overhang that directly pressures NNOX shares.

  • Going-concern doubt after Q2 report Nano-X ended Q2 with $31.4 million cash, down from $60 million, and management warned of substantial doubt about continuing as a going concern. A $40.7 million impairment and $55.5 million net loss deepen fears of a cash crunch, pushing the stock down.

    Going-concern doubt is a severe new risk that directly threatens the company's survival and stock price.

  • Revenue growth but slow commercialization Q2 revenue rose 37% to $4.2 million, with teleradiology up 14% and AI/software adding $1 million. The first Nanox Imaging Network site began collecting insurance payments, but management admitted commercialization is slower than expected, tempering the positive growth.

    This shows the underlying business is growing but not fast enough to offset cash burn, a key tension for the stock.

  • Restructuring and manufacturing shift Nano-X is idling its South Korean chip fabrication, cutting that workforce by 67% and Israeli headcount by 15%, and shifting to third-party manufacturing. The plan saves only $2 million a year from 2027, raising doubts about its impact.

    The restructuring is a direct response to the cash crisis and signals deeper operational problems.

Latest
▼3

Nano-X: Q2 revenue up 37% but going-concern doubt and lawsuits weigh

  • Securities class action lawsuits pile up Multiple law firms filed class actions alleging Nano-X overstated efficiency and demand, hid rising costs and cash burn, and misled investors. Legal costs, potential damages, and reputational damage weigh on the stock, though the suits are still pending.

    This is a major new legal overhang that directly pressures NNOX shares.

  • Going-concern doubt after Q2 report Nano-X ended Q2 with $31.4 million cash, down from $60 million, and management warned of substantial doubt about continuing as a going concern. A $40.7 million impairment and $55.5 million net loss deepen fears of a cash crunch, pushing the stock down.

    Going-concern doubt is a severe new risk that directly threatens the company's survival and stock price.

  • Revenue growth but slow commercialization Q2 revenue rose 37% to $4.2 million, with teleradiology up 14% and AI/software adding $1 million. The first Nanox Imaging Network site began collecting insurance payments, but management admitted commercialization is slower than expected, tempering the positive growth.

    This shows the underlying business is growing but not fast enough to offset cash burn, a key tension for the stock.

  • Restructuring and manufacturing shift Nano-X is idling its South Korean chip fabrication, cutting that workforce by 67% and Israeli headcount by 15%, and shifting to third-party manufacturing. The plan saves only $2 million a year from 2027, raising doubts about its impact.

    The restructuring is a direct response to the cash crisis and signals deeper operational problems.

Q2 2026
▼3▲1

Nanox Q1: Going-Concern Doubt, Guidance Withdrawn, Lawsuits Mount

  • Q1 2026: Going-concern doubt and guidance withdrawn Nanox reported Q1 revenue of $4.3 million but withdrew its 2026 revenue target and said it will no longer give annual guidance. It also disclosed $44.2 million in cash is not enough to fund the next 12 months, raising substantial doubt about its ability to continue as a going concern. This directly pressures the stock because it signals possible cash shortage and no clear revenue visibility.

    This is the core new fundamental event that explains the period's negative move.

  • Securities class action lawsuits over alleged misleading statements Multiple law firms announced securities class actions alleging Nanox overstated efficiency gains and demand while hiding manufacturing problems. The lawsuits cover purchases from March 31, 2025 to April 17, 2026, with a lead plaintiff deadline of August 11, 2026. This adds legal costs and uncertainty, weighing on the stock.

    New legal actions create fresh financial and reputational risk for NNOX.

  • South Korea operations may be sold or wound down Nanox is evaluating strategic alternatives for its South Korea operations, including a potential sale or wind-down. This follows a $17.5 million impairment and $18 million restructuring plan disclosed in April. A sale or shutdown could reduce future costs but also signals that part of the business is failing, hurting investor confidence.

    This is a new strategic update that affects the company's cost structure and future prospects.

  • First commercial Nanox.ARC system in use at RadNet Nanox reported that a Nanox.ARC system is now in commercial use at a RadNet facility. This is a small but important milestone showing the product is finally being deployed in a real clinical setting. If it leads to more orders, it could support future revenue, but so far it is just one unit.

    This is the only new positive operational development that could offset the negative financial news.

June 2026
▼3▲1

Nanox Q1: Going-Concern Doubt, Guidance Withdrawn, Lawsuits Mount

  • Q1 2026: Going-concern doubt and guidance withdrawn Nanox reported Q1 revenue of $4.3 million but withdrew its 2026 revenue target and said it will no longer give annual guidance. It also disclosed $44.2 million in cash is not enough to fund the next 12 months, raising substantial doubt about its ability to continue as a going concern. This directly pressures the stock because it signals possible cash shortage and no clear revenue visibility.

    This is the core new fundamental event that explains the period's negative move.

  • Securities class action lawsuits over alleged misleading statements Multiple law firms announced securities class actions alleging Nanox overstated efficiency gains and demand while hiding manufacturing problems. The lawsuits cover purchases from March 31, 2025 to April 17, 2026, with a lead plaintiff deadline of August 11, 2026. This adds legal costs and uncertainty, weighing on the stock.

    New legal actions create fresh financial and reputational risk for NNOX.

  • South Korea operations may be sold or wound down Nanox is evaluating strategic alternatives for its South Korea operations, including a potential sale or wind-down. This follows a $17.5 million impairment and $18 million restructuring plan disclosed in April. A sale or shutdown could reduce future costs but also signals that part of the business is failing, hurting investor confidence.

    This is a new strategic update that affects the company's cost structure and future prospects.

  • First commercial Nanox.ARC system in use at RadNet Nanox reported that a Nanox.ARC system is now in commercial use at a RadNet facility. This is a small but important milestone showing the product is finally being deployed in a real clinical setting. If it leads to more orders, it could support future revenue, but so far it is just one unit.

    This is the only new positive operational development that could offset the negative financial news.

▼3▲1

Nanox Q1: Going-Concern Doubt, Guidance Withdrawn, Lawsuits Mount

  • Q1 2026: Going-concern doubt and guidance withdrawn Nanox reported Q1 revenue of $4.3 million but withdrew its 2026 revenue target and said it will no longer give annual guidance. It also disclosed $44.2 million in cash is not enough to fund the next 12 months, raising substantial doubt about its ability to continue as a going concern. This directly pressures the stock because it signals possible cash shortage and no clear revenue visibility.

    This is the core new fundamental event that explains the period's negative move.

  • Securities class action lawsuits over alleged misleading statements Multiple law firms announced securities class actions alleging Nanox overstated efficiency gains and demand while hiding manufacturing problems. The lawsuits cover purchases from March 31, 2025 to April 17, 2026, with a lead plaintiff deadline of August 11, 2026. This adds legal costs and uncertainty, weighing on the stock.

    New legal actions create fresh financial and reputational risk for NNOX.

  • South Korea operations may be sold or wound down Nanox is evaluating strategic alternatives for its South Korea operations, including a potential sale or wind-down. This follows a $17.5 million impairment and $18 million restructuring plan disclosed in April. A sale or shutdown could reduce future costs but also signals that part of the business is failing, hurting investor confidence.

    This is a new strategic update that affects the company's cost structure and future prospects.

  • First commercial Nanox.ARC system in use at RadNet Nanox reported that a Nanox.ARC system is now in commercial use at a RadNet facility. This is a small but important milestone showing the product is finally being deployed in a real clinical setting. If it leads to more orders, it could support future revenue, but so far it is just one unit.

    This is the only new positive operational development that could offset the negative financial news.

US Dollar/Korean Won FX Spot Rate (USDKRW.FOREX)

Q3 2026
▲3

Won surges on rate hikes, chip dollars, and intervention

  • Bank of Korea rate hikes The Bank of Korea raised interest rates for the first time in 3.5 years, to 2.75% and then 3.00%, making won deposits more attractive and pulling foreign capital into Korea, which strengthened the won.

    Higher rates directly increase demand for the won, a key force behind its rise.

  • SK Hynix share sale and repatriation SK Hynix's $7 billion share sale and $26.5 billion repatriation of overseas earnings flooded the market with dollars for sale, boosting the won as the chipmaker converted foreign cash into local currency.

    This massive dollar supply was a major driver of won strength.

  • Market opening and bullish calls Plans to open won trading to foreigners and Goldman Sachs' bullish call on AI-driven surpluses increased optimism, drawing more investors to the won and supporting its rise past 1,400 per dollar.

    These developments improved sentiment and foreign demand for the won.

  • Intervention and retail outflows Coordinated intervention with Japan and the US supported the won, but authorities warned strength was 'excessive' and retail investors bought $4.6 billion of US stocks in July, a capital outflow that could weaken the won.

    This shows both support and counterweights to the won's rise.

August 2026
▼3

Won climbs on BOK hikes, chip inflows, exporter dollar sales

  • Bank of Korea hikes twice to 3.00%, signals more South Korea's central bank raised its policy rate by 0.25% on August 27 to 3.00%, its second straight hike and highest in 19 months, and hinted at 3.25% ahead. Higher rates make won deposits more attractive, pulling foreign money in and strengthening the won, which pushes USDKRW down.

    This is the period's biggest new monetary event and directly strengthens the won.

  • Won breaks past 1,400 on chip boom and SK Hynix cash The won strengthened past 1,400 per dollar for the first time in over 10 months, helped by a semiconductor recovery and SK Hynix converting 26.5 billion dollars from a US listing back into won. That selling of dollars and buying of won pushes USDKRW lower.

    It marks a new milestone and shows real capital flows driving the won stronger.

  • South Korea pushes exporters to bring dollars home Asian central banks are shifting from burning reserves to attracting inflows, and South Korea is pressing exporters to repatriate dollar earnings. That converts foreign currency into won, adding demand for the won and pushing USDKRW down.

    It is a new policy tactic that adds steady won demand beyond rate hikes.

  • Retail investors buy US stocks, a counterweight to won strength In July, South Korean retail investors bought 4.6 billion dollars of US stocks, the most in six months, as the domestic market slumped. That sends money abroad and can weaken the won, but it was offset by SK Hynix's repatriation, so the net effect on USDKRW is mixed.

    It is the main real counterweight that could slow or reverse the won's rise.

Latest
▼3

Won climbs on BOK hikes, chip inflows, exporter dollar sales

  • Bank of Korea hikes twice to 3.00%, signals more South Korea's central bank raised its policy rate by 0.25% on August 27 to 3.00%, its second straight hike and highest in 19 months, and hinted at 3.25% ahead. Higher rates make won deposits more attractive, pulling foreign money in and strengthening the won, which pushes USDKRW down.

    This is the period's biggest new monetary event and directly strengthens the won.

  • Won breaks past 1,400 on chip boom and SK Hynix cash The won strengthened past 1,400 per dollar for the first time in over 10 months, helped by a semiconductor recovery and SK Hynix converting 26.5 billion dollars from a US listing back into won. That selling of dollars and buying of won pushes USDKRW lower.

    It marks a new milestone and shows real capital flows driving the won stronger.

  • South Korea pushes exporters to bring dollars home Asian central banks are shifting from burning reserves to attracting inflows, and South Korea is pressing exporters to repatriate dollar earnings. That converts foreign currency into won, adding demand for the won and pushing USDKRW down.

    It is a new policy tactic that adds steady won demand beyond rate hikes.

  • Retail investors buy US stocks, a counterweight to won strength In July, South Korean retail investors bought 4.6 billion dollars of US stocks, the most in six months, as the domestic market slumped. That sends money abroad and can weaken the won, but it was offset by SK Hynix's repatriation, so the net effect on USDKRW is mixed.

    It is the main real counterweight that could slow or reverse the won's rise.

July 2026
▲4

Won surges on rate hike, dollar sales, and intervention

  • Bank of Korea's first rate hike in 3.5 years The Bank of Korea raised its policy rate to 2.75%, the first hike in 3.5 years. Higher rates make won-denominated assets more attractive, drawing foreign capital and strengthening the won.

    This is a major new monetary policy shift that directly boosted the won.

  • Massive dollar sales from SK Hynix and exporters SK Hynix's $7bn share sale and chip/shipbuilding exporters sold dollars, increasing won demand. This one-off supply of dollars helped push the won higher.

    Large dollar sales are a key new flow that strengthened the won.

  • Plans to open won trading to foreigners and Goldman's bullish call Plans to open won trading to foreigners from 2027 and Goldman Sachs' forecast of an AI-driven current account surplus near $300bn boosted confidence in the won.

    These new reform and forecast factors improved sentiment and attracted capital.

  • Coordinated intervention with Japan and US support Rare coordinated intervention with Japan and US support weakened the dollar against the won. However, authorities warned won weakness was 'excessive', hinting discomfort with rapid moves.

    Intervention was a direct new force driving the won higher, though with caveats.

▼4

Won surges on reforms, AI-driven surplus, and coordinated intervention

  • South Korea to ease won trading rules from 2027 South Korea will let foreigners trade the won freely among themselves from 2027, cutting red tape and opening the currency to more global money. More foreign demand for won strengthens the won, pushing USDKRW down.

    This regulatory shift increases long-term demand for the won, a key new force behind USDKRW's move.

  • Goldman Sachs bullish on won, sees AI-driven surplus doubling Goldman Sachs is bullish on the won, forecasting South Korea's current account surplus will nearly double to about $300 billion this year thanks to AI investment. A bigger surplus means more dollars flowing in, which supports the won and pushes USDKRW lower.

    This explains the fundamental demand for won from AI-driven exports and investment, a new driver this period.

  • Won hits four-month high on strong data and rate-hike bets The won extended gains, nearing a four-month high and heading for a 6.5% monthly rally, as strong South Korean economic data and expectations of further Bank of Korea rate hikes offset a stock market selloff. Higher rates and solid growth attract foreign money, strengthening the won and pushing USDKRW down.

    This shows the won's broad rally driven by domestic strength, a new development this period.

  • South Korea joins Japan in rare coordinated intervention South Korea and Japan both bought their currencies on Thursday, with U.S. support, in a rare joint move. South Korea sold dollars to prop up the won, which jumped to its strongest since October 2025. This direct dollar-selling strengthens the won and pushes USDKRW down.

    This is a major new event that directly and immediately strengthened the won, a key driver of USDKRW's move.

▼4

Korean Won Strengthens on Rate Hike and Big Dollar Sales

  • Bank of Korea raises rates to defend won The Bank of Korea raised its policy rate to 2.75%, the first hike in three and a half years, to stabilize the weakening won. Higher rates make Korean assets more attractive, drawing foreign money and strengthening the won, which pushes USDKRW lower.

    This is a major new monetary policy shift that directly supports the won and answers why USDKRW is falling.

  • SK Hynix dollar sale boosts won SK Hynix's US share sale raised $7 billion, with proceeds converted into won around July 15. This large dollar-selling flow increased demand for the won, sending USDKRW to a one-month low near 1,498.

    A concrete, large capital flow that directly increased won demand and pushed USDKRW down.

  • Chip and shipbuilding firms sell dollars South Korea's Finance Ministry said major semiconductor and shipbuilding companies are selling large amounts of dollars, improving foreign exchange supply. This structural shift, backed by a record trade surplus, supports the won and weighs on USDKRW.

    Official confirmation of a broad, structural dollar-selling trend that strengthens the won.

  • Authorities push back against won weakness South Korean officials said the won's weakness is excessive and not justified by strong fundamentals, hinting at intervention. Suspected intervention near 1,550 and official comments have helped the won recover, pushing USDKRW lower.

    Shows official resistance to further won weakness, a key force capping USDKRW.